IMPACT Therapeutics
Nanjing
About IMPACT Therapeutics
IMPACT Therapeutics creates new treatments to treat cancer and other life-threatening disorders. The firm is committed to the discovery and development of targeted anti-cancer treatments based on synthetic lethality, hence offering patients novel targeted anti-cancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $179.8M
- Funding stage: Late Stage Venture
- Last round: Series D (Nov 2024)
- Website: impacttherapeutics.com
- Phone: +02558619059
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/impact-therapeutics-19001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.